# Exocrine-Endocrine Pancreatic Crosstalk: Precision Pathways to Reframe Diabetes Pathophysiology

> **NCT07670871** · — · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 440 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)
- Chronic Pancreatitis
- Prediabetes
- Pancreatic Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07670871
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2029-11
- **Final completion:** 2031-09
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07670871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07670871, "Exocrine-Endocrine Pancreatic Crosstalk: Precision Pathways to Reframe Diabetes Pathophysiology". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07670871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*